Refractory Tumors
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase I Safety Study of DMXAA in Refractory Tumors (NCT00856336) | Antisoma Research | 2003-05-01 |
| Temozolomide in Association With Topotecan in Refractory or Relapsed Malignant Tumors in Children and Adolescents (NCT00412503) | Gustave Roussy, Cancer Campus, Grand Paris |
Track Refractory Tumors automatically
Every clearance here is in the API, with alerts when new ones post.